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Between September and October 2018, an enterovirus 
D68 (EV-D68) outbreak occurred in patients 
hospitalised with severe acute respiratory infection 
in northern Italy; 21 laboratory-confirmed cases were 
reported. Phylogenetic analysis revealed that 16/20 of 
the EV-D68 sequences belonged to a divergent group 
within the sub-clade D1. Since its upsurge, EV-D68 
has undergone rapid evolution with the emergence of 
new viral variants, emphasising the need for molecular 
surveillance that include outpatients with respiratory 
illness.
An enterovirus D68 (EV-D68) outbreak was recognised 
at a major tertiary centre and research hospital in 
Milan and Pavia in the Lombardy region, northern 
Italy, respectively, between September and October 
2018. Here, we present the molecular and clinical 
characteristics of the confirmed EV-D68 cases detected 
during the outbreak sustained by EV-D68 sub-clade D1 
strains.
 
Enterovirus D68 detection
From 1 August to 30 October 2018, routine laboratory 
testing on 853 respiratory samples, collected from 
patients hospitalised with respiratory infection, were 
analysed using molecular assays to detect causing 
respiratory viruses and bacteria. Of these, 91 (10.7%) 
tested positive for rhinovirus/EV and were further 
analysed using a real-time one-step RT (reverse-
transcription)-PCR assay targeting the 5’ untranslated 
region (5’UTR) of EV-D68 [1,2]; 21 samples were positive 
for EV-D68 and no other viruses or bacteria were 
identified. Among EV-D68-positive samples, 10 were 
nasopharyngeal aspirates (NPA), eight nasopharyngeal 
swabs (NS) and three broncho-alveolar lavages (BAL).
 
Characteristics of patients with enterovirus 
D68 infection
Of 21 EV-D68-positive cases, the median age was 18 
years (range: 1 month–84 years) and 14 were male. 
An underlying or concurrent condition was reported 
for 10 patients (Table). Underlying conditions were: 
genetic/metabolic disorder (n = 4); leukaemia (n 
= 3); cystic fibrosis (n = 1); chronic heart disease (n 
= 1); and lymphoma (n = 1). Sixteen of 21 EV-D68-
positive patients had signs and/or symptoms of lower 
respiratory tract infection (LRTI) and five showed 
symptoms of mild respiratory infection (Table). Among 
LRTI cases, five patients required intensive care unit 
(ICU) admission due to respiratory failure.
Phylogenetic and molecular analysis
Complete viral protein (VP)1 nt sequences [3] were 
obtained for 20 of 21 EV-D68 strains (GenBank 
accession numbers: MK301336-MK301355). A maximum 
likelihood phylogenetic tree was inferred using IQ-Tree 
web server (v1.6.8) [4] and the robustness of branches 
was evaluated using the Shimodaira–Hasegawa 
approximate likelihood-ratio test (SH-aLRT) and 
ultrafast bootstrap approximation tests.
Unexpectedly, most (16/20) sequences clustered into 
a distinct genetic group within the D clade, with a 
bootstrap value of 99% (Figure). Clade D has recently 
been reclassified into two sub-clades (referred as D1 
and D2) [5,6]. The Italian strains clustered with one 
Taiwanese strain collected in 2016, one United States 
(US) strain collected in 2017 and 13 French strains 
collected in 2018 (shown in green in  Figure), which 
together composed a divergent D1-like group. The 
average nt identity between EV-D68 strains belonging 
to this divergent group was 98.0%; the sequences 
shared an average nt identity of 96.3% (range: 94.7–
97.8%) with all available D1 strains (n = 69) retrieved 
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from GenBank and 93.2% (range: 92.1–94.4%) with all 
available D2 strains (n = 7). The remaining four EV-D68 
strains detected during the outbreak belonged to sub-
clade B2 and clustered with strains collected in 2018 
in France.
All VP1 sequences of EV-D68 strains belonging to 
the divergent D1-like group differed from sub-clade 
D1 by the V299I change. A series of polymorphisms, 
such as T98V and I243V, was observed in several 
subgroups of sequences. In addition, 12 of 16 Italian 
sequences harboured the I17M change and the 
remaining four strains showed the I13V change. Four 
polymorphisms (98V, 102L, 142T and 143D) observed in 
the Italian strains were within codons of protein motifs 
corresponding to the BC and DE loops (Figure).
Discussion and conclusion
In 2008, EV-D68 was first reported in Italy [3,7]. In 
2014 and 2016, the US and several European countries 
experienced a surge in the number of severe acute 
respiratory infection cases caused by EV-D68 infection, 
sustained by strains belonging to multiple EV-D68 
clades [8,9];
These outbreaks, in particular the one that occurred 
in 2016, were chronologically and geographically 
superimposed by an unprecedented cluster of acute 
flaccid myelitis (AFM) cases, with a striking clinical 
similarity to poliomyelitis in patients with respiratory 
prodromal illness [8]. Two AFM cases associated with 
EV-D68 were recognised in the same period in Italy 
[10,11]. The association between EV-D68 infection and 
AFM was confirmed recently [12-14], triggering public 
health concern [15]. Following the 2014 outbreak, 
improved EV-D68 surveillance has revealed EV-D68 
Table
Characteristics of patients with enterovirus D68 infection, northern Italy, 1 August–30 October 2018 (n = 21)
Age group 
(years)
Underlying 
disease Respiratory illness
ICU 
admission
Type of 
sample 
analysed
Sample 
collection 
month
Strain name EV-D68 sub-clade
80–89 Yes Bronchiolitis No NS September EV-ITA-684–2018 D1-like
20–29 Yes SARI and bronchial asthma Yes NPA September EV-ITA-685–2018 D1-like
40–49 Yes Bronchiolitis No NS September EV-ITA-686–2018 D1-like
60–69 NA Rhinorrhea No NS September EV-ITA-19478–2018 D1-like
1–9 No Pneumonia No NS September EV-ITA-19704–2018 D1-like
70–79 NA Pneumonia No BAL September EV-ITA-19705–2018 D1-like
<1 No Recurrent bronchospasms No NS September EV-ITA-19957–2018 D1-like
70–79 Yes Pneumonia No NS September EV-ITA-689–2018 D1-like
<1 No Febrile wheezing No NPA September EV-ITA-20100–2018 D1-like
30–39 NA Rhinorrhea and cough No NS September EV-ITA-20181–2018 D1-like
10–19 Yes SARI and bronchial asthma Yes BAL September EV-ITA-687–2018 D1-like
1–9 No SARI and bronchial asthma Yes NPA September EV-ITA-688–2018 B2-like
20–29 Yes SARI and bronchial asthma No NPA September EV-ITA-690–2018 D1-like
10–19 No SARI and bronchial asthma Yes NPA September EV-ITA-683–2018 D1-like
1–9 Yes Rhinorrhea and cough No NPA September EV-ITA-693–2018 D1-like
1–9 Yes SARI and bronchial asthma Yes NPA September EV-ITA-695–2018 B2-like
60–69 Yes Pneumonia No NS October EV-ITA-694–2018 D1-like
1–9 No SARI and bronchial asthma No NPA October EV-ITA-696–2018 NA
1–9 No Rhinorrhea and cough No NPA October EV-ITA-751–2018 B2-like
<1 No SARI and bronchial asthma No NPA October EV-ITA-753–2018 B2-like
80–89 Yes Cough and pneumonia No BAL October EV-ITA-757–2018 D1-like
BAL: broncho-alveolar lavage; EV-D68: enterovirus D68; ICU: intensive care unit; NA: not available; NPA: nasopharyngeal aspirate; NS: nasal 
swab; SARI: severe acute respiratory infection.
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circulation in several countries in Europe and North 
America [2,8,16].
In our study, none of EV-D68-positive patients showed 
signs or symptoms of neurological impairment. 
However, in line with previous reports [17-19], 16 of 
21 EV-D68-positive patients in our series had severe 
respiratory infections and five of them required ICU 
admission. A limitation of our series is that we included 
only inpatients with clinical illness that required 
hospitalisation, thus the severity of EV-D68 infections 
may have been overestimated. In addition, presence 
of underlying conditions in some patients could have 
made the outcome of EV-D68 infection more severe. 
Involving general practitioners in EV-D68 surveillance 
among outpatients with respiratory illness could help 
improve the current knowledge regarding the clinical 
characteristics of EV-D68 infection and the proportion 
of severe disease among those infected.
Figure 
Phylogenetic rooted tree inferred by maximum likelihood of complete enterovirus D68 VP1 sequences, northern Italy, 
1 August–30 October 2018 (n = 20)
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The phylogenetic analysis of EV-D68 sequences 
indicates that, over the past two decades, four clades 
(A to D) and multiple sub-lineages have emerged and 
spread rapidly worldwide [5,8,16]. The phylogenetic 
analysis of EV-D68 strains identified during the 
outbreak in Italy and in France (August–November 
2018), underlined a wave of EV-D68 activity in 
Europe and revealed the presence of EV-D68 strains 
segregating into a divergent group within sub-clade D1 
sequences. Based on the genetic distance analyses, 
this group of new D1-like sequences showed less 
genetic divergence from D1 (average 3.7%) than that 
previously observed between D1 and D2 (average 
5.2%) [6]; we thus cannot consider this group as a 
new sub-clade. The re-emergence of EV-D68 strains 
belonging to two ‘old’ sub-clades (B2 and D1) suggests 
that amino acid variations have occurred over the 
last few years. Several amino acidic changes were 
observed in residues located on the surface BC and 
DE loops resulting in a diversification of antigenic 
epitopes [20]. These polymorphisms may be signatures 
of these divergent D1 strains, it is unclear, however, 
whether they possess a selective advantage. Overall, a 
continuous emergence and replacement of clades and 
sub-clades with a biennial pattern of circulation has 
been observed worldwide [5,8].
Our findings raise attention of the rapid emergence 
of new EV-D68 variants that could be associated with 
unexpected and possible severe clinical syndromes 
such as AFM. So far there is no direct evidence of the 
association of neurological impairment with a specific 
EV-D68 variant. Studies are needed to investigate the 
host-pathogen relationship during infection and to 
clarify the association between genetic diversity and 
clinical outcome. Sharing virological, epidemiological 
and clinical data on EV-D68 will enable a better 
understanding of the elusive pathogenesis of EV-D68.
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